This inventor holds 1 USPTO granted patent and 3 published patent applications. Active years: 2026.
Years Active: 2026
Title: Liping Pettus: Innovator in Macrocyclic Compounds
Introduction
Liping Pettus is a notable inventor based in Thousand Oaks, CA (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific mutations in the KRAS gene, which are associated with various cancers.
Latest Patents
Liping Pettus holds 1 patent for her work on macrocyclic compounds and methods of use. Her patent focuses on compounds that inhibit KRAS mutations, including G12D, G12V, G12A, G12S, G13D, Q61H, Q61L, and G12C. The compounds are described by a general Formula I′, with specific variables defined in the disclosure. This innovation also includes pharmaceutical compositions that utilize these compounds for cancer treatment.
Career Highlights
Throughout her career, Liping Pettus has demonstrated a commitment to advancing medical science through her innovative research. Her work has the potential to impact cancer therapies significantly, providing new avenues for treatment options.
Collaborations
Liping has collaborated with esteemed colleagues, including Wei Zhao and Michael M Yamano, to further her research and development efforts in this critical area of study.
Conclusion
Liping Pettus is a pioneering inventor whose work on macrocyclic compounds represents a significant advancement in cancer treatment. Her contributions to the field highlight the importance of innovation in addressing complex medical challenges.